254 related articles for article (PubMed ID: 22923426)
1. Role of BMPR2 alternative splicing in heritable pulmonary arterial hypertension penetrance.
Cogan J; Austin E; Hedges L; Womack B; West J; Loyd J; Hamid R
Circulation; 2012 Oct; 126(15):1907-16. PubMed ID: 22923426
[TBL] [Abstract][Full Text] [Related]
2. Synergistic heterozygosity for TGFbeta1 SNPs and BMPR2 mutations modulates the age at diagnosis and penetrance of familial pulmonary arterial hypertension.
Phillips JA; Poling JS; Phillips CA; Stanton KC; Austin ED; Cogan JD; Wheeler L; Yu C; Newman JH; Dietz HC; Loyd JE
Genet Med; 2008 May; 10(5):359-65. PubMed ID: 18496036
[TBL] [Abstract][Full Text] [Related]
3. Alu-mediated nonallelic homologous and nonhomologous recombination in the BMPR2 gene in heritable pulmonary arterial hypertension.
Kataoka M; Aimi Y; Yanagisawa R; Ono M; Oka A; Fukuda K; Yoshino H; Satoh T; Gamou S
Genet Med; 2013 Dec; 15(12):941-7. PubMed ID: 23579436
[TBL] [Abstract][Full Text] [Related]
4. BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis.
Evans JD; Girerd B; Montani D; Wang XJ; Galiè N; Austin ED; Elliott G; Asano K; Grünig E; Yan Y; Jing ZC; Manes A; Palazzini M; Wheeler LA; Nakayama I; Satoh T; Eichstaedt C; Hinderhofer K; Wolf M; Rosenzweig EB; Chung WK; Soubrier F; Simonneau G; Sitbon O; Gräf S; Kaptoge S; Di Angelantonio E; Humbert M; Morrell NW
Lancet Respir Med; 2016 Feb; 4(2):129-37. PubMed ID: 26795434
[TBL] [Abstract][Full Text] [Related]
5. Penetrance of pulmonary arterial hypertension is modulated by the expression of normal BMPR2 allele.
Hamid R; Cogan JD; Hedges LK; Austin E; Phillips JA; Newman JH; Loyd JE
Hum Mutat; 2009 Apr; 30(4):649-54. PubMed ID: 19206171
[TBL] [Abstract][Full Text] [Related]
6. Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension.
Hautefort A; Mendes-Ferreira P; Sabourin J; Manaud G; Bertero T; Rucker-Martin C; Riou M; Adão R; Manoury B; Lambert M; Boet A; Lecerf F; Domergue V; Brás-Silva C; Gomez AM; Montani D; Girerd B; Humbert M; Antigny F; Perros F
Circulation; 2019 Feb; 139(7):932-948. PubMed ID: 30586714
[TBL] [Abstract][Full Text] [Related]
7. Connectivity map analysis of nonsense-mediated decay-positive BMPR2-related hereditary pulmonary arterial hypertension provides insights into disease penetrance.
Flynn C; Zheng S; Yan L; Hedges L; Womack B; Fessel J; Cogan J; Austin E; Loyd J; West J; Zhao Z; Hamid R
Am J Respir Cell Mol Biol; 2012 Jul; 47(1):20-7. PubMed ID: 22312021
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations.
Pfarr N; Szamalek-Hoegel J; Fischer C; Hinderhofer K; Nagel C; Ehlken N; Tiede H; Olschewski H; Reichenberger F; Ghofrani AH; Seeger W; Grünig E
Respir Res; 2011 Jul; 12(1):99. PubMed ID: 21801371
[TBL] [Abstract][Full Text] [Related]
9. Abnormal trafficking of endogenously expressed BMPR2 mutant allelic products in patients with heritable pulmonary arterial hypertension.
Frump AL; Lowery JW; Hamid R; Austin ED; de Caestecker M
PLoS One; 2013; 8(11):e80319. PubMed ID: 24224048
[TBL] [Abstract][Full Text] [Related]
10. Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertension.
Austin ED; Phillips JA; Cogan JD; Hamid R; Yu C; Stanton KC; Phillips CA; Wheeler LA; Robbins IM; Newman JH; Loyd JE
Respir Res; 2009 Sep; 10(1):87. PubMed ID: 19785764
[TBL] [Abstract][Full Text] [Related]
11. Modulation of Endothelial Bone Morphogenetic Protein Receptor Type 2 Activity by Vascular Endothelial Growth Factor Receptor 3 in Pulmonary Arterial Hypertension.
Hwangbo C; Lee HW; Kang H; Ju H; Wiley DS; Papangeli I; Han J; Kim JD; Dunworth WP; Hu X; Lee S; El-Hely O; Sofer A; Pak B; Peterson L; Comhair S; Hwang EM; Park JY; Thomas JL; Bautch VL; Erzurum SC; Chun HJ; Jin SW
Circulation; 2017 Jun; 135(23):2288-2298. PubMed ID: 28356442
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of pulmonary arterial hypertension in affected carriers of a mutation located in the cytoplasmic tail of bone morphogenetic protein receptor type 2.
Girerd B; Coulet F; Jaïs X; Eyries M; Van Der Bruggen C; De Man F; Houweling A; Dorfmüller P; Savale L; Sitbon O; Vonk-Noordegraaf A; Soubrier F; Simonneau G; Humbert M; Montani D
Chest; 2015 May; 147(5):1385-1394. PubMed ID: 25429696
[TBL] [Abstract][Full Text] [Related]
13. BMPRII influences the response of pulmonary microvascular endothelial cells to inflammatory mediators.
Vengethasamy L; Hautefort A; Tielemans B; Belge C; Perros F; Verleden S; Fadel E; Van Raemdonck D; Delcroix M; Quarck R
Pflugers Arch; 2016 Nov; 468(11-12):1969-1983. PubMed ID: 27816994
[TBL] [Abstract][Full Text] [Related]
14. Reduction of
Theobald V; Benjamin N; Seyfarth HJ; Halank M; Schneider MA; Richtmann S; Hinderhofer K; Xanthouli P; Egenlauf B; Seeger R; Hoeper MM; Jonigk D; Grünig E; Eichstaedt CA
Genes (Basel); 2022 Apr; 13(5):. PubMed ID: 35627145
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic protein receptor type 2 mutations, clinical phenotypes and outcomes of Japanese patients with sporadic or familial pulmonary hypertension.
Kabata H; Satoh T; Kataoka M; Tamura Y; Ono T; Yamamoto M; Huqun ; Hagiwara K; Fukuda K; Betsuyaku T; Asano K
Respirology; 2013 Oct; 18(7):1076-82. PubMed ID: 23675998
[TBL] [Abstract][Full Text] [Related]
16. High frequency of BMPR2 exonic deletions/duplications in familial pulmonary arterial hypertension.
Cogan JD; Pauciulo MW; Batchman AP; Prince MA; Robbins IM; Hedges LK; Stanton KC; Wheeler LA; Phillips JA; Loyd JE; Nichols WC
Am J Respir Crit Care Med; 2006 Sep; 174(5):590-8. PubMed ID: 16728714
[TBL] [Abstract][Full Text] [Related]
17.
Song J; Hinderhofer K; Kaufmann LT; Benjamin N; Fischer C; Grünig E; Eichstaedt CA
Genes (Basel); 2020 Oct; 11(10):. PubMed ID: 33036198
[TBL] [Abstract][Full Text] [Related]
18. De novo mutations in the BMPR2 gene in patients with heritable pulmonary arterial hypertension.
Momose Y; Aimi Y; Hirayama T; Kataoka M; Ono M; Yoshino H; Satoh T; Gamou S
Ann Hum Genet; 2015 Mar; 79(2):85-91. PubMed ID: 25612240
[TBL] [Abstract][Full Text] [Related]
19. Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension.
Tojais NF; Cao A; Lai YJ; Wang L; Chen PI; Alcazar MAA; de Jesus Perez VA; Hopper RK; Rhodes CJ; Bill MA; Sakai LY; Rabinovitch M
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1559-1569. PubMed ID: 28619995
[TBL] [Abstract][Full Text] [Related]
20. Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertension.
Johnson JA; Hemnes AR; Perrien DS; Schuster M; Robinson LJ; Gladson S; Loibner H; Bai S; Blackwell TR; Tada Y; Harral JW; Talati M; Lane KB; Fagan KA; West J
Am J Physiol Lung Cell Mol Physiol; 2012 Mar; 302(5):L474-84. PubMed ID: 22180660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
